ICMR will choose 20 healthcare facilities, largely government-run hospitals, across India to begin clinical trials for convalescent plasma transfusion therapy, a treatment that is being explored for critically-ill Covid-19 patients.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XXXyzy
via Latest News of India
Post a Comment